Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
BioCeryx
AddedFeb 16, 2024
UpdatedJun 18, 2026
BioCeryx

BioCeryx

Series A

BioCeryx: Developing accessible molecular diagnostic platforms through fluidics, engineering, and bioinformatics.

HQ
Menlo Park, CA, US
Founded
2017
Overview
Compare
Fundraising
Employees

BioCeryx is dedicated to developing molecular diagnostic platforms to make diagnostics accessible and enhance patient therapy. Their services integrate fluidics, engineering, and bioinformatics to simplify complex diagnostic routines. The company focuses on improving healthcare outcomes through innovative technology.

BioCeryx has made significant strides in the field of molecular diagnostics, contributing to more accessible and efficient patient care. Their platform's integration of advanced technologies has positioned them as a key player in the diagnostic industry, impacting healthcare delivery positively.

BioCeryx - Similar Companies

BioFluidica logo

BioFluidica

biofluidica.com

Caspr logo

Caspr

Techcyte logo

Techcyte

techcyte.com

Fluxergy logo

Fluxergy

fluxergy.com

BioAnalytics logo

BioAnalytics

FYR Diagnostics logo

FYR Diagnostics

fyrdiagnostics.com

RareCyte logo

RareCyte

rarecyte.com

Probius logo

Probius

probius.bio

Droplet Biosciences logo

Droplet Biosciences

dropletbiosci.com

Prompt Diagnostics logo

Prompt Diagnostics

prompt-dx.com

Smart Diagnostics Systems logo

Smart Diagnostics Systems

Nanopath logo

Nanopath

nanopathdx.com

Biological Dynamics logo

Biological Dynamics

Aegirbio logo

Aegirbio

aegirbio.com

Cytovale logo

Cytovale

cytovale.com

BioCeryx - Quick Facts

Who are BioCeryx's competitors?

Companies similar to BioCeryx include BioFluidica, Caspr, Techcyte and Fluxergy.

When was BioCeryx founded?

BioCeryx was founded in 2017.

Where is BioCeryx's headquarters located?

BioCeryx's headquarters is located in Menlo Park, CA, US.

When was BioCeryx's last funding round?

BioCeryx's most recent funding round was for $5M (USD) in February 2018.

How much has BioCeryx raised to-date?

As of Feb 20, 2018, BioCeryx has raised a total of $5M (USD).

How many employees does BioCeryx have?

BioCeryx has 30 employees as of Feb 5, 2024.

BioCeryx - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • AI
  • Bioinformatics
Geographic Exposure
  • Global
Model
  • Platform
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Diagnostic Platforms
Tags
  • Biotech
  • Healthcare
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 4 more industry codes
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified